Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Phase 3 Type 2 diabetes trial achieved its primary endpoint, with HbA1c reductions of up to 1.68%, demonstrating non-inferiority across all dose levels versus dapagliflozin, with the highest dose showing superior HbA1c reduction
Hollingshead, B
New drug approved for hyperphagia in Prader-Willi syndrome
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
We pay attention to more than the scale: how you feel, move, sleep, and function all matter
Can it help you survive COVID-19
US$ 28.02
US$ 26.74
US$ 27.99
US$ 28.41
US$ 22.90
US$ 28.20
US$ 21.21
US$ 20.78
US$ 21.43
